Description
Venclexta (Venetoclax) 100mg Online
Venclexta (Venetoclax) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing.
It is used to treat chronic lymphocytic leukemia, small lymphocytic lymphoma, and acute myelogenous leukemia.
BCL2 inhibitors are used to treat certain types of leukemia. They block a specific protein ( B-cell lymphoma-2), which causes the leukemia cells to go through normal cell death, stopping cancer cell growth.
Venetoclax is used alone or in combination with obinutuzumab (Gazyva) or rituximab (Rituxan) to treat certain types of chronic lymphocytic leukemia (CLL; a type of cancer that begins in the white blood cells) or certain types of small lymphocytic lymphoma (SLL; a type of cancer that begins mostly in the lymph nodes). It is also used in combination with either azacitidine (Vidaza), decitabine (Dacogen), or cytarabine as the first treatment for acute myeloid leukemia (AML;
a type of cancer that begins in the white blood cells) in people 75 years of age or older, or in adults who have medical conditions that prevent them from being treated with other chemotherapy medications. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It works by blocking the action of a certain protein in the body that helps cancer cells survive. This helps to kill cancer cells.
Venetoclax comes as a tablet to take by mouth. It is usually taken with a meal and water once a day. Take venetoclax at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take venetoclax exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
